ArticleJournal of hematology & oncology2018

Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXA.

Simon Heine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.